The salvage of recurrent endometrial carcinoma in the vagina and pelvis.
A retrospective analysis was performed on 93 patients who developed recurrent endometrial carcinoma in the pelvis, vaginal vault, and lower 1/3 vagina. There were 12 lower 1/3 vaginal recurrences, 24 vault recurrences and 57 pelvic recurrences from the 1005 patients treated between 1960 and 1976. Median time to recurrence was 30 months. Twenty-six patients had distant metastases also present at the time of recurrence in the sites mentioned above. Thirty-three percent of lower 1/3 vaginal recurrences, 12.5% of vault recurrences, and 5.3% of pelvic recurrences were salvaged with further treatment. The 10-year actuarial survival rates of isolated lower 1/3 vaginal, vaginal vault, and pelvic recurrences were 50%, 45%, and 24% respectively.
Poulsen
M G
MG
Queensland Radium Institute, Royal Brisbane Hospital, Australia.
Roberts
S J
SJ
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000556:secondary; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010386:Pelvic Neoplasms / Q000532:radiotherapy / Q000556:secondary*; D011379:Prognosis; D014594:Uterine Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D014625:Vaginal Neoplasms / Q000532:radiotherapy / Q000556:secondary*